<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" orientation="portrait" position="anchor">
 <label>Table 1. </label>
 <caption>
  <title>Neutralisation test results by Kenya Medical Research Institute KEMRI-Wellcome Trust Research Programme (KEMRI-WTRP) and BEI laboratories of samples from BEI Resources respiratory syncytial virus (RSV) Reference panel catalogue #NR-32832 which contains 5 different pooled human polyclonal antisera to RSV.</title>
 </caption>
 <table frame="hsides" rules="groups" content-type="article-table">
  <thead>
   <tr>
    <th align="left" rowspan="2" valign="top" colspan="1">Reference sample</th>
    <th align="center" valign="top" rowspan="1" colspan="1">Expected titer range 
     <break/>provided by BEI in 2011
    </th>
    <th align="center" valign="top" rowspan="1" colspan="1">KEMRI-WTRP</th>
   </tr>
   <tr>
    <th align="center" valign="top" rowspan="1" colspan="1">in 2011</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Mean log 
     <sub>2</sub> neut titer
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">BEI NR-4020 
     <break/>Wyeth lot 6594
    </td>
    <td align="center" rowspan="1" colspan="1">8.79 
     <break/>(±6.48)
    </td>
    <td align="center" rowspan="1" colspan="1">8.93 
     <break/>(8.61-9.20)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">BEI NR-4021 
     <break/>Wyeth lot 6937 - high
    </td>
    <td align="center" rowspan="1" colspan="1">10.88 
     <break/>(±9.75)
    </td>
    <td align="center" rowspan="1" colspan="1">10.29 
     <break/>(9.91-10.60)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">BEI NR-4022 
     <break/>Wyeth lot 6938 - medium
    </td>
    <td align="center" rowspan="1" colspan="1">7.81 
     <break/>(±5.81)
    </td>
    <td align="center" rowspan="1" colspan="1">8.75 
     <break/>(8.12-9.19)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">BEI NR-4023 
     <break/>Wyeth lot 6939 - low
    </td>
    <td align="center" rowspan="1" colspan="1">8.28 
     <break/>(±2.81)
    </td>
    <td align="center" rowspan="1" colspan="1">8.73 
     <break/>(8.25-9.08)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">BEI NR-21973 
     <break/>CBER reference Ig lot RSV-1
    </td>
    <td align="center" rowspan="1" colspan="1">7.56 
     <break/>(±5.21)
    </td>
    <td align="center" rowspan="1" colspan="1">8.59 
     <break/>(8.09-8.96)
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Palivizumab (Synagis) 
     <break/>100 mg/ml
    </td>
    <td align="center" rowspan="1" colspan="1"/>
    <td align="center" rowspan="1" colspan="1">(Assayed a 1% 
     <break/>solution of stock Ab) 
     <break/>10.59 
     <break/>(10.43-10.73) 
     <break/>Undiluted = 17.23
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
